Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of March 31, 2025 • 4:31 PM ET

Date/Time Source News Release
03/28/2025 07:00 AM EDT GlobeNewswire FDA Issues Complete Response Letter for Etripamil for PSVT
03/20/2025 08:00 AM EDT GlobeNewswire Milestone Pharmaceuticals to Present Clinical Data on Etripamil at the American College of Cardiology
03/13/2025 07:08 AM EDT GlobeNewswire Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update
03/04/2025 08:00 AM EST GlobeNewswire Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/27/2025 08:00 AM EST GlobeNewswire Milestone® Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
02/19/2025 08:00 AM EST GlobeNewswire Milestone® Pharmaceuticals Notice of Allowance on New U.S. Patent for Etripamil
02/11/2025 08:00 AM EST GlobeNewswire Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025
01/28/2025 08:00 AM EST GlobeNewswire Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC
01/07/2025 08:00 AM EST GlobeNewswire Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/25/2024 08:00 AM EST GlobeNewswire Milestone Pharmaceuticals to Present at the Piper Sandler 36th Annual Healthcare Conference
Page

Additional News

As of March 31, 2025 • 4:31 PM ET

Date/Time Source News Release
03/28/2025 03:16 PM EDT SeekingAlpha SA Asks: Which small/mid-cap cardiology stocks are undervalued?
03/28/2025 07:19 AM EDT SeekingAlpha Milestone Pharma says FDA declined to approve heart disorder therapy
03/21/2025 03:18 PM EDT SeekingAlpha Milestone Pharmaceuticals: A Compelling Value Proposition For Patients And Payers
03/14/2025 05:31 AM EDT US Earnings Reports Expected earnings - Milestone Pharmaceuticals Inc.
03/13/2025 09:15 AM EDT SeekingAlpha Milestone Pharmaceuticals GAAP EPS of -$0.19
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Milestone Pharmaceuticals Inc.
11/19/2024 09:55 AM EST Zacks After Golden Cross, Milestone Pharmaceuticals (MIST)'s Technical Outlook is Bright
11/12/2024 05:09 PM EST SeekingAlpha Milestone Pharmaceuticals files for mixed shelf offering
11/12/2024 10:31 AM EST SeekingAlpha Milestone Pharmaceuticals GAAP EPS of -$0.14
08/22/2024 03:12 PM EDT SeekingAlpha Milestone wins Buy at Rodman & Renshaw on potential Cardamyst approval
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.